← Eichor
Condition: Gi Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Gi Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Establishment and Validation of a Clinical Predictive Model for Gastrointestinal Cancer Screening Based on Patient-relat
Phase N/A · 1 location(s) · Air Force Military Medical University, China · NCT06118437Resilience and Equity in Aging, Cancer, and Health (REACH)
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT04674267A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
Phase 1/Phase 2 · 9 location(s) · DualityBio Inc. · NCT07263594The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Phase N/A · 1 location(s) · Western Sydney Local Health District · NCT05804331Personalized Health Self-Management Training for Colorectal Cancer Survivors
NA · 2 location(s) · University of Southern California · NCT05984589A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Canc
Phase 1 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06500052Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Phase 1/Phase 2 · 62 location(s) · Merck Sharp & Dohme LLC · NCT06596694Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
NA · 2 location(s) · University of California, San Francisco · NCT04221893Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepat
Phase N/A · 1 location(s) · University of Chicago · NCT01416714Endoscopic Application of Tranexamic Acid and Sucralfate in Gastrointestinal Tumor Bleeding: A Randomized Controlled Tri
NA · 1 location(s) · National Cheng-Kung University Hospital · NCT07540026Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Ma
Phase 2 · 1 location(s) · John Waters · NCT07039526Collection of Information to Better Understand Young Onset Colorectal Cancer
Phase N/A · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT04489238Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers
Phase 2 · 2 location(s) · Genmab · NCT07539311Stress Ball Use During Chemotherapy in Gastrointestinal Cancer Patients
NA · 1 location(s) · Artvin Coruh University · NCT07383935Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Per
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT04847063Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral Neuropathy in Gastrointestinal (GI
NA · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferso · NCT07501663Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
NA · 7 location(s) · Chinese Academy of Sciences · NCT06002425Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme
Phase 2 · 41 location(s) · UNICANCER · NCT06475352Improving Comprehensive Care of Cancer Patients
NA · 1 location(s) · Baylor College of Medicine · NCT05323409KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Lin
Phase 2 · 16 location(s) · Kumquat Biosciences Inc. · NCT07406633Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Phase 1 · 10 location(s) · Nammi Therapeutics Inc · NCT06582017Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Phase 1 · 3 location(s) · Fox Chase Cancer Center · NCT05274048TARGETed Therapy Drug MONITOring in DIGestive Oncology
NA · 29 location(s) · UNICANCER · NCT05443087Multicomponent Prehabilitation and Outcomes in Elderly Patients With Frailty
NA · 1 location(s) · Peking University First Hospital · NCT04715581Dyadic Sleep Study
NA · 2 location(s) · University of Miami · NCT06569693Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI
Phase 1/Phase 2 · 1 location(s) · National University Hospital, Singapore · NCT05381038Omega-3 Fatty Acids and Nutritional Support in Gastrointestinal Cancer
NA · 1 location(s) · Maimónides Biomedical Research Institute of Córdoba · NCT06015971Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT04354064Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Muta
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT03190941Extracellular Vesicles and Chemotherapy-Induced Peripheral Neuropathy
NA · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT07558447
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.